Robert Rymowicz, DO
Robert Rymowicz, DO, FAPA
Robert Rymowicz, DO is a board-certified psychiatrist and addiction specialist practicing in Arizona with clinical expertise in addiction psychiatry and general psychiatry. He earned his medical degree from Western University of Health Sciences and completed his psychiatry residency at Rutgers New Jersey Medical School, where he served as chief resident. Dr. Rymowicz further pursued subspecialty training with a fellowship in addiction psychiatry at the UCLA David Geffen School of Medicine.
In clinical practice, he focuses on the assessment and treatment of substance use disorders, including opioid, alcohol, stimulant, and other addictive conditions, and incorporates evidence-based psychotherapeutic approaches such as cognitive behavioral therapy. Dr. Rymowicz provides care in outpatient and telehealth settings in the greater Phoenix area and is board-certified in both psychiatry and addiction medicine.
He has also been involved in professional leadership and education within psychiatry and addiction medicine communities, contributing to ongoing efforts to advance high-quality, multidisciplinary care for individuals with co-occurring mental health and substance use disorders.
Pallavi Joshi, DO
Pallavi Joshi, DO, FAPA
Pallavi Joshi, DO, MA is a geriatric psychiatrist based in Phoenix, Arizona, serving as a clinician at Banner Alzheimer’s Institute and an Assistant Clinical Professor of Psychiatry at the University of Arizona College of Medicine–Phoenix. She also serves in leadership roles in the Geriatric Psychiatry Fellowship program.
Dr. Joshi earned her medical degree from Western University of Health Sciences and completed her psychiatry residency at Northwell Health–Staten Island University Hospital, where she was Chief Resident. She went on to complete a fellowship in Geriatric Psychiatry at Yale School of Medicine.
Dr. Joshi has published and presented research in geriatric psychiatry, addiction psychiatry, and neuropsychology at national conferences, and has held leadership and scientific committee positions with the American Association for Geriatric Psychiatry, the American Psychiatric Association, and the American Academy of Addiction Psychiatry.
Amie Kafer, DO
Amie Kafer, DO, FAPA
Amie Kafer, DO is a board-certified psychiatrist practicing in Phoenix, Arizona. She graduated from Midwestern University Arizona College of Osteopathic Medicine and completed her residency in psychiatry at Maricopa Integrated Health System.
Dr. Kafer has more than 15 years of experience in the mental health field and has worked extensively within the public behavioral health system in the Phoenix area. She has served in both inpatient and outpatient psychiatric roles and currently practices outpatient psychiatry at Valleywise Behavioral Health Centers, including providing care to diverse populations such as individuals living with HIV, those receiving PrEP care, and patients seeking gender-affirming services.
Dr. Kafer speaks both English and Spanish and is certified by the American Board of Psychiatry and Neurology.
Sue Sisley, MD
Sue Sisley, MD
Sue Sisley, MD is an American physician specializing in Internal Medicine and Psychiatry, and a leading clinical researcher focused on plant-based medicines such as cannabis and psilocybin. She earned her medical degree from the University of Arizona College of Medicine and completed a dual residency in Internal Medicine and Psychiatry.
Dr. Sisley is President and Principal Investigator of the Scottsdale Research Institute, where she conducts FDA-approved clinical trials investigating the safety and efficacy of naturally occurring compounds—including cannabis—in conditions like post-traumatic stress disorder (PTSD), chronic pain, and opioid dependence.
She is best known for leading the only FDA-approved randomized controlled study of whole-plant cannabis in combat veterans with severe PTSD and advocates for reforming federal restrictions that impede research into Schedule I substances. Her work has helped break federal barriers to quality plant medicine research in the United States.